FASEB J. Pierce now sold as Thermo Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


FJ EXPRESS SUMMARY ARTICLE
The
Full-length version of this article is also available, published online February 26, 2001 as doi:10.1096/fj.00-0530fje.
Published as doi: 10.1096/fj.00-0530fje.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/7/1329
00-0530fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIU, Z.
Right arrow Articles by LEIBOWITZ, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIU, Z.
Right arrow Articles by LEIBOWITZ, S. F.
(The FASEB Journal. 2001;15:1329-1331.)
© 2001 FASEB

Apolipoprotein D interacts with the long-form leptin receptor: a hypothalamic function in the control of energy homeostasis1

ZHITONG LIU, GUO-QING CHANG and SARAH F. LEIBOWITZ2

The Rockefeller University, New York, New York 10021, USA

2Correspondence: The Rockefeller University, Box 278, 1230 York Ave., New York, NY 10021, USA. E-mail: leibow{at}rockvax.rockefeller.edu

SPECIFIC AIM

To identify and clone genes that are expressed in the hypothalamus and involved in the development of obesity through the regulation of food intake and body fat accrual.

PRINCIPAL FINDINGS

1. Identification of Apo D
We used representational difference analysis (RDA) to identify genes that exhibit increased expression in the hypothalamus of rats maintained on a high-fat diet, which is known to cause obesity and stimulate hypothalamic expression of peptides involved in energy balance. We then investigated whether any of these RDA clones encode proteins that interact with the long-form receptor of leptin, which controls food intake and body weight and is stimulated by a high-fat diet. We performed this experiment by screening a yeast two-hybrid library and searching the resultant clones for DNA sequences identical to those generated by RDA.

In the RDA experiment, the cDNA fragments prepared from the medial hypothalamus of rats (Sprague-Dawley, male, n=10/group) maintained for 3 wk on a low-fat diet (10% fat, 3.75 Kcal/g) were subtracted from those of the rats on a high-fat diet (60%, 5.10 Kcal/g) diet, and the resultant cDNA fragments were amplified by PCR. After three rounds of subtraction and amplification, distinct DNA bands were obtained in agarose gel. The subsequent cloning and sequencing of these DNA fragments (53 clones) revealed a clone containing a 0.5 kb cDNA fragment of Apo D. In a GAL4 yeast two-hybrid system, the cytoplasmic domain immediately following the transmembrane region of rat Ob-Rb, hereafter referred as Ob-Rbc (for carboxyl terminal), was used as the bait to screen a rat brain cDNA library (2x106 yeast colonies). Sequencing of 57 positive clones from an X-GAL filter assay revealed a clone that contained a 0.9 kb amino-terminal truncated cDNA fragment of Apo D.

2. Dietary fat stimulates Apo D expression in the hypothalamus
To confirm that dietary fat stimulates the hypothalamic mRNA level of Apo D, we measured Apo D mRNA in the medial hypothalamus by quantitative RT-PCR in an additional set of rats (n=5–6/group) maintained for 3 wk on either a low-fat (10%), moderate-fat (30%), or high-fat (60%) diet. The results demonstrate that the relative (to actin) Apo D mRNA level increases significantly as dietary fat rises from 10% to 30% (+19%, P<0.03) and even further in rats on a 60% fat diet (+25%, P<0.001). This increase in dietary fat concentration and Apo D mRNA was accompanied by a significant rise in circulating levels of leptin. Body fat pad weights (retroperitoneal, inguinal, mesenteric, and epididymal), as well as body weight and total daily intake, were also elevated in the high-fat diet rats.

3. Apo D interacts with Ob-Rb
To confirm the binding between Apo D and Ob-Rbc, we tested their interaction in a different LexA yeast two-hybrid system. In these experiments, only the yeast harboring Apo D and Ob-Rbc fusion proteins grew, and the resultant colonies turned blue within 3 days on the test medium, demonstrating that Apo D interacts specifically with Ob-Rbc.

We confirmed this interaction with purified proteins by protein-to-protein interaction experiments in vitro. Apo D and Ob-Rbc were expressed in bacteria as a GST fusion protein and a thioredoxin (Trx) fusion protein, respectively, and purified. It was found that 20 µg of Trx·Ob-Rbc coprecipitated with 1 µg of GST · Apo D, but not with 1 µg of GST when GST and GST · Apo D were precipitated with glutathione agarose beads. Reciprocally, 1 µg of GST · Apo D coprecipitated with 20 µg of Trx · Ob-Rbc, but not with 20 µg of Trx, when Trx and Trx · Ob-Rbc were precipitated with Ni-NTA SuperflowTM resin.

4. Apo D does not interact with Ob-Ra
Since the mutation of Ob-Rb into the natural short form, Ob-Ra, results in obesity in C57BL/ks db-/db- mice, it was interesting to investigate whether Apo D also interacts with Ob-Ra. We expressed the cytoplasmic domain of rat Ob-Ra (Ob-Rac) as a Trx fusion protein (Trx · Ob-Rac) in bacteria and purified it. In a protein-to-protein interaction experiment, 1 µg of GST · Apo D did not coprecipitate with 20 µg of Trx · Ob-Rac when Trx · Ob-Rac was precipitated by Ni-NTA SuperflowTM resin. Apo D did not interact with Ob-Rac in the LexA yeast two-hybrid system. Therefore, through independent approaches, we have demonstrated that Apo D fails to interact with Ob-Ra.

The above experiments indicate that the amino acid sequence responsible for the interaction with Apo D is present in Ob-Rbc but not Ob-Rac. To confirm this, we generated a truncated Ob-Rbc (Ob-Rbt) by removing a stretch of sequence at the NH2 terminus of Ob-Rbc. We found that 20 µg of Trx · Ob-Rbt coprecipitated with 1 µg of GST · Apo D but not with 1 µg of GST when GST and GST · Apo D were precipitated with glutathione agarose beads. Reciprocally, 1 µg of GST · Apo D coprecipitated with 20 µg of Trx · Ob-Rbt, but not with 20 µg Trx · Ob-Rac, when the Trx fusion proteins were precipitated by Ni-NTA SuperflowTM resin. These experiments indicate that Ob-Rbt is sufficient for the interaction between Apo D and Ob-Rbc. However, the amino acids or motifs on both Apo D and Ob-Rbt involved in this interaction remain to be determined.

We also demonstrated the interaction between Apo D and Ob-R in vivo in immunoprecipitation experiments with proteins extracted from pooled rat hypothalamus (Fig. 1 ). A single band of ~30 kDa, representing the glycosylated Apo D, was detected (Fig. 1 , lane 1). In contrast, a mock precipitation generated no signal (Fig. 1 , lane 2).



View larger version (34K):
[in this window]
[in a new window]
 
Figure 1. Protein-to-protein interaction in vivo. Ob-R and its associated proteins were precipitated by a goat anti-Ob-R antibody (lane 1) from protein extracts made from pooled rat hypothalamus at 4°C overnight. After washing 4 times, proteins were separated in a 10% polyacrylamide gel and assayed for Apo D by a monoclonal anti-human Apo D antibody. Apo D was not detected in a mock precipitation (lane 2) conducted by using normal goat IgG in the precipitation step.

5. Apo D and Ob-Rb are coexpressed in hypothalamic neurons
By using a monoclonal anti-human Apo D antibody, we also observed the existence of Apo D protein in neurons of hypothalamic nuclei in immunohistochemical experiments. As shown in Fig. 2 (top panel), the immunoreactivity for Apo D is evident in the cytoplasm of neurons, both parvocellular and magnocellular, of the paraventricular nucleus and in small neurons of the arcuate nucleus. This immunoreactivity is specific to Apo D protein, since no signal was generated when the above antibody was preabsorbed by purified human Apo D (not shown). Ob-R immunoreactivity is also present in neurons of the paraventricular and arcuate nuclei, as revealed by using a polyclonal anti-Ob-R antibody (Fig. 2 , middle panel). In this double-labeling experiment, we found that the proteins of both Apo D and Ob-R are clearly colocalized in the same neurons of these hypothalamic nuclei (Fig. 2 , lower panel). This coexistence is also observed in other areas, including the hypothalamic supraoptic nucleus, cortex, and choroid plexus (not shown).



View larger version (110K):
[in this window]
[in a new window]
 
Figure 2. Colocalization of Apo D and Ob-R protein in hypothalamic nuclei. The monoclonal anti-human Apo D antibody and goat polyclonal anti-Ob-R antibody were used. The immunoreactivity was detected by fluorescein- and cyanine-3-conjugated secondary antibodies, respectively, and examined under a confocal microscope. Apo D and Ob-R protein are observed in the same neurons of the paraventricular (PVN) and arcuate (ARC) nuclei of the hypothalamus.

6. Hypothalamic Apo D mRNA levels correlate positively with body fat and circulating leptin
We used quantitative RT-PCR to determine relative Apo D mRNA levels in the medial hypothalamus of rats exhibiting differential body fat accrual on a high-fat diet. In this experiment, Sprague-Dawley rats were fed ad libitum on a high-fat diet for 3 wk. Based on the amount of body fat accumulated (measured in four dissected depots) over this period, these subjects were then divided into two subgroups, referred to as ‘lean’ (n=7) with 15–21 g body fat or ‘obese’ (n=8) with 26–34 g body fat. Whereas both groups were similar in their total daily intake, the obese rats with ~50% greater body fat had significantly higher Apo D mRNA levels in the medial hypothalamus (1.57±0.05 vs. 1.38±0.04, P<0.05). They also had considerably higher levels of circulating leptin (21.5±3.1 vs. 9.8±2.0, P<0.05). Across the whole group, Apo D mRNA was found to be strongly, positively correlated with total body fat (r=+0.87, P<0.01), body weight (r=+0.82, P<0.01), and the level of leptin (r=+0.76, P<0.01), which in turn was positively related to adiposity (r=+0.87, P<0.01). Similar results were obtained in inbred mouse strains (SWR/J and AKR/J) with a differential propensity toward obesity.

7. Apo D mRNA levels are reduced in medial hypothalamus of ob-/ob- and db-/db- mice
We further investigated whether Apo D remains positively associated with body fat mass in mouse strains that are obese due to a mutated leptin or Ob-Rb gene. We first examined Apo D expression in C57BL/3j db-/db- mice using quantitative RT-PCR. Due to their mutational loss of the cytoplasmic portion of Ob-Rb, these mice presumably do not support an interaction between Apo D and the mutant Ob-Rb. The level of medial hypothalamic Apo D mRNA in C57BL/3j db-/db- mice was found to be considerably reduced relative to that of the wild-type mice (0.69±0.01 vs. 0.88±0.01, P<0.05). To investigate the influence of the loss of leptin itself on Apo D expression, we compared hypothalamic Apo D mRNA in obese C57BL/6j ob-/ob- mice to that of the lean wild-type C57BL/6j mice. With a mutant leptin but intact Ob-Rb in C57BL/6j ob-/ob- mice, Ob-Rb could not be stimulated, even though it may still interact with Apo D. Similar to the result in db-/db- mice, the Apo D mRNA level was 30% lower in the C57BL/6j ob-/ob- mice compared to their lean wild-type littermates (0.71±0.01 vs. 1.06±0.01, P<0.05). These findings, indicating that a functional leptin/Ob-Rb signaling process is required for the up-regulation of Apo D expression, support a possible role for hypothalamic Apo D in the control of body fat accrual.

CONCLUSIONS AND SIGNIFICANCE

We provide strong evidence suggesting that Apo D interacts with Ob-Rb, but not Ob-Ra, in hypothalamic neurons in vivo. We have also found that fat intake significantly stimulates hypothalamic expression of Apo D, which in turn is strongly, positively correlated with body fat pad weights and circulating levels of leptin. However, the mutant ob-/ob- and db-/db- mice have considerably reduced levels of hypothalamic Apo D mRNA compared to their lean wild-type littermates. These findings indicate that the leptin/Ob-Rb signaling pathway modulates Apo D expression in hypothalamic neurons. We propose that the reduced expression of hypothalamic Apo D in ob-/ob- and db-/db- mice, possibly resulting in a deficiency of Apo D protein, contributes to the development of the obesity, particularly on a high-fat diet.

Apo D belongs to the lipocalin protein family, the members of which bind and transport small hydrophobic ligands. However, the specific ligand to which Apo D binds has not been unequivocally identified. Published evidence suggests that Apo D may bind to multiple ligands, and each ligand is specific to the tissue or cell type where Apo D is expressed. We thus speculate that Apo D may be activated through its interaction with a leptin-stimulated Ob-Rb and may bind a specific ligand in hypothalamic neurons, where it exerts signaling functions. This ligand may be produced after leptin stimulation and serve as a paracrine signal within particular hypothalamic nuclei or a hormone that enters the circulation. Apo D may thus play a contributing role in the regulation of body fat accrual. This proposed function of hypothalamic Apo D is consistent with a previous report that a Taq I Apo D polymorphism is linked to obesity and hyperinsulinemia, as well as to noninsulin-dependent diabetes mellitus, a condition commonly associated with obesity in animals and humans.FIGURE 3



View larger version (13K):
[in this window]
[in a new window]
 
Figure 3. Hypothesis. Dietary fat stimulates Apo D expression of in hypothalamic neurons as well as leptin production. Through its interaction with the carboxyl terminus of activated Ob-Rb, Apo D may be stimulated, probably resulting in a conformational change. This stimulation may enable Apo D to bind a putative ligand, which is thought to be generated through the activation of Ob-Rb by leptin. Apo D may transport this ligand as a paracrine signal within particular hypothalamic nuclei or carry this ligand as a hormone to specific locations of the body through circulation.

FOOTNOTES

1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.00-0530fje ; to cite this article, use FASEB J. (February 22, 2001) 10.1096/fj.00-0530fje




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
Y.-W. Chen, C. M. Gregory, M. T. Scarborough, R. Shi, G. A. Walter, and K. Vandenborne
Transcriptional pathways associated with skeletal muscle disuse atrophy in humans
Physiol Genomics, November 14, 2007; 31(3): 510 - 520.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. C.Y. Leung, A. Lawrie, S. Demaries, H. Massaeli, A. Burry, S. Yablonsky, J. M. Sarjeant, E. Fera, E. Rassart, J. G. Pickering, et al.
Apolipoprotein D and Platelet-Derived Growth Factor-BB Synergism Mediates Vascular Smooth Muscle Cell Migration
Circ. Res., July 23, 2004; 95(2): 179 - 186.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
15/7/1329
00-0530fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LIU, Z.
Right arrow Articles by LEIBOWITZ, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LIU, Z.
Right arrow Articles by LEIBOWITZ, S. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS